电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

SARS-CoV-2 Nucleocapsid 产品

(SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N))

Categories

antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.

Featured SARS-CoV-2 Nucleocapsid Categories

SARS-CoV-2 Nucleocapsid 抗体

High quality antibodies with extensive validation data.

SARS-CoV-2 Nucleocapsid 蛋白

Proteins for various applications incl. WB, ELISA, IF etc.

Recommended SARS-CoV-2 Nucleocapsid 抗体

Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity SARS Coronavirus-2 (SARS-CoV-2), Virus
Application ELISA, WB
Validations
  • (6)
  • (3)
Cat. No. ABIN6952435
Quantity 100 μL
Datasheet Datasheet
Reactivity SARS Coronavirus-2 (SARS-CoV-2)
Application ELISA, WB, GICA
Validations
  • (1)
  • (2)
Cat. No. ABIN6952664
Quantity 100 μL
Datasheet Datasheet
Reactivity SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)
Application ELISA, IF
Validations
  • (3)
  • (2)
Cat. No. ABIN6953059
Quantity 200 μg
Datasheet Datasheet

Recommended SARS-CoV-2 Nucleocapsid ELISA试剂盒

Product
Reactivity
Analytical Method
Validations
Cat. No.
Quantity
Datasheet
Reactivity Human, SARS Coronavirus-2 (SARS-CoV-2)
Analytical Method Quantitative Sandwich ELISA
Validations
Cat. No. ABIN6952756
Quantity 96 tests
Datasheet Datasheet

Recommended SARS-CoV-2 Nucleocapsid 蛋白

Product
Reactivity
Source
Validations
Cat. No.
Quantity
Datasheet
Reactivity SARS Coronavirus-2 (SARS-CoV-2)
Source HEK-293 Cells
Validations
  • (5)
  • (2)
Cat. No. ABIN6952454
Quantity 100 μg
Datasheet Datasheet
Reactivity SARS Coronavirus-2 (SARS-CoV-2)
Source Escherichia coli (E. coli)
Validations
  • (1)
  • (2)
Cat. No. ABIN6952658
Quantity 200 μg
Datasheet Datasheet
Reactivity SARS Coronavirus-2 (SARS-CoV-2)
Source Escherichia coli (E. coli)
Validations
  • (1)
Cat. No. ABIN7274433
Quantity 100 μg
Datasheet Datasheet

Latest Publications for our SARS-CoV-2 Nucleocapsid Products

Qiao, Wotring, Zhang, Jiang, Xiao, Watt, Gattis, Scandalis, Freier, Zheng, Pretto, Ellison, Swayze, Guo, Sexton, Chinnaiyan: "Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection." in: PloS one, Vol. 18, Issue 2, pp. e0281281, (2023) (PubMed).

Rabdano, Ruzanova, Pletyukhina, Saveliev, Kryshen, Katelnikova, Beltyukov, Fakhretdinova, Safi, Rudakov, Arakelov, Andreev, Kofiadi, Khaitov, Valenta, Kryuchko, Berzin, Belozerova, Evtushenko, Truhin et al.: "Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell®. ..." in: Vaccines, Vol. 11, Issue 4, (2023) (PubMed).

Gaynor, Vaysburd, Harman, Albecka, Jeffrey, Beswick, Papa, Chen, Mallery, McGuinness, Van Rietschoten, Stanway, Brear, Lulla, Ciazynska, Chang, Sharp, Neary, Box, Herriott, Kijak, Tatham, Bentley et al.: "Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2. ..." in: Nature communications, Vol. 14, Issue 1, pp. 3583, (2023) (PubMed).

Qiao, Wotring, Zheng, Zhang, Zhang, Jiang, Pretto, Eyunni, Parolia, He, Cheng, Cao, Wang, Su, Ellison, Wang, Qin, Yan, Zhou, Ma, Sexton, Chinnaiyan: "Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Issue 30, pp. e2221809120, (2023) (PubMed).

Wotring, Fursmidt, Ward, Sexton: "Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern." in: Journal of dairy science, (2022) (PubMed).

Sherman, Mirabelli, Tang, Khan, Leix, Kennedy, Graham, Willer, Tai, Sexton, Wobus, Emmer: "Identification of cell type specific ACE2 modifiers by CRISPR screening." in: PLoS pathogens, Vol. 18, Issue 3, pp. e1010377, (2022) (PubMed).

Ramm, Dondapati, Trinh, Wenzel, Walter, Zemella, Kubick: "The Potential of Eukaryotic Cell-Free Systems as a Rapid Response to Novel Zoonotic Pathogens: Analysis of SARS-CoV-2 Viral Proteins." in: Frontiers in bioengineering and biotechnology, Vol. 10, pp. 896751, (2022) (PubMed).

Ren, Irudayaraj: "Paper-Based Test for Rapid On-Site Screening of SARS-CoV-2 in Clinical Samples." in: Biosensors, Vol. 11, Issue 12, (2022) (PubMed).

Mirabelli, Sherman, Wotring, El Saghir, Bragazzi Cunha, Harder, Sexton, Emmer, Wobus: "ARF6 is an important host factor for SARS-CoV-2 infection in vitro." in: bioRxiv : the preprint server for biology, (2022) (PubMed).

Meister, Gottsauner, Schmidt, Heinen, Todt, Audebert, Buder, Lang, Gessner, Steinmann, Vielsmeier, Pfaender, Cieplik: "Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial." in: Virus research, Vol. 316, pp. 198791, (2022) (PubMed).

Synonyms and alternative names related to SARS-CoV-2 Nucleocapsid

nucleocapsid phosphoprotein (N)
You are here:
客服